Neurology > > General Neurology– News and commentary from the world of neurology and neuroscience
by Judy George, Deputy Managing Editor, MedPage Today February 20, 2024
A potential research study in Sweden reported a link in between herpes simplex infection and dementia. (Journal of Alzheimer's Disease
Scientist separated individuals with Parkinson's illness from healthy controls with 68% precision utilizing retinal fundus imaging. (Scientific Reports
Clinicians require to think about the political context of preclinical medical diagnoses of neurodegenerative illness, ethicists argued. (JAMA Neurology
German scientists revealed that SARS-CoV-2 did not continue brain cells and supported the concept that COVID's neurologic issues might be because of inflammatory immune responses. (Nature Neuroscience
Majority of individuals with long COVID reported experiencing cognitive signs daily, according to a U.S. study. (JAMA Network Open
Information from the University of Washington revealed SARS-CoV-2 infection was related to a considerable boost in event tiredness and persistent tiredness. (Emerging Infectious Diseases
In a mouse design, terrible brain injury resulted in modifications in practical connection beyond the instant location of effect. (Cortex
The FDA set a June 21 due date to choose whether to broaden delandistrogene moxeparvovec (Elevidys)'s indicator for Duchenne muscular dystrophy and transform the treatment's sped up approval to conventional approval, Sarepta stated.
The stage II HIMALAYA research study of SAR443820 (DNL788) in amyotrophic lateral sclerosis didn't satisfy its main endpoint, however the investigational RIPK1 inhibitor will continue being studied in numerous sclerosis, according to Sanofi and Denali Therapeutics.
Complete information from the stage IIIb ELEVATE trial revealing that atogepant (Qulipta) decreased mean month-to-month migraine days in treatment-resistant episodic migraine were released in Lancet NeurologyTrial findings formerly existed at the 2023 American Academy of Neurology conference.
Artist and songwriter Brian Wilson has a “significant neurocognitive condition” and is taking medication for dementia, according to a petition submitted to put the 81-year-old Beach Boys co-founder in conservatorship. (AP
-
Judy George covers neurology and neuroscience news for MedPage Today, blogging about brain aging, Alzheimer's, dementia, MS, unusual illness, epilepsy, autism, headache, stroke, Parkinson's, ALS, concussion, CTE, sleep, discomfort, and more. Follow
